Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun
dimebolin
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word latrepirdine.
Examples
-
The Company's product pipeline includes Dimebon - also known by its generic name, latrepirdine - a drug being developed as a treatment for mild-to-moderate Alzheimer's disease.
-
Feb 9 (ANI): Dimebon (latrepirdine), a pill being developed for Alzheimer's mental abilities in some patients with Huntington's ...
-
An early stage clinical trial of the experimental drug dimebon (latrepirdine) in people with Huntington's disease appears to be safe and may improve cognition.
Science Blog BJS 2010
-
Dimebon (latrepirdine), a pill being developed for Alzheimer's disease, has been found to improve mental abilities in some patients with Huntington's disease, says a new study.
Medindia Health News 2010
-
The two companies are testing Dimebon, known chemically as latrepirdine, in three additional studies involving patients with moderate to severe Alzheimer's, and in one involving patients with Huntington's disease.
Latest News Nancy Kearney 2010
-
An early stage clinical trial of the experimental drug dimebon (latrepirdine) in people with Huntington's disease appears to be safe and may improve cognition.
Science Blog BJS 2010
-
The job cuts come three weeks after data from the 598-patient CONNECTION trial which showed that Dimebon (latrepirdine), which is partnered with Pfizer, did not meet its co-primary or secondary efficacy endpoints compared to placebo.
-
The job cuts come three weeks after data from the 598-patient CONNECTION trial which showed that Dimebon (latrepirdine), which is partnered with Pfizer, did not meet its co-primary or secondary efficacy endpoints compared to placebo.
-
The Company's product pipeline includes Dimebon - also known by its generic name, latrepirdine - a drug being developed as a treatment for mild-to-moderate Alzheimer's disease.
-
In September 2008, Medivation announced a global agreement with Pfizer, Inc to develop and commercialize dimebon (latrepirdine) for the treatment of Alzheimer's and Huntington diseases.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.